Yukio NAKAMURA (2018) “Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis”, Archives of Rheumatology, 33(2), pp. 154–159. doi: 10.5606/ArchRheumatol.2018.6366.